Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Oncolytic Virus Therapy Market 2018 Forecast to 2023

Publisher Name :
Date: 27-Apr-2018
No. of pages: 108

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Scope of the Report:

This report focuses on the Oncolytic Virus Therapy in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Amgen

- Oncolytics Biotech

- Viralytics

- Transgene SA

- Oncolys BioPharma

- Targovax

- PsiOxus Therapeutics

- SillaJen Biotherapeutics

- Sorrento Therapeutics

- Lokon Pharma

- Genelux Corporation

- Vyriad

- TILT Biotherapeutics

- Cold Genesys

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into

- Melanoma

- Prostate Cancer

- Breast Cancer

- Ovarian Cancer

- Others

There are 15 Chapters to deeply display the global Oncolytic Virus Therapy market.

Chapter 1, to describe Oncolytic Virus Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oncolytic Virus Therapy, with sales, revenue, and price of Oncolytic Virus Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncolytic Virus Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oncolytic Virus Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oncolytic Virus Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Oncolytic Virus Therapy Market 2018 Forecast to 2023

Table of Contents

1 Market Overview
1.1 Oncolytic Virus Therapy Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Melanoma
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Oncolytic Virus Therapy Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Amgen Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Oncolytics Biotech
2.2.1 Business Overview
2.2.2 Oncolytic Virus Therapy Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Viralytics
2.3.1 Business Overview
2.3.2 Oncolytic Virus Therapy Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Viralytics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Transgene SA
2.4.1 Business Overview
2.4.2 Oncolytic Virus Therapy Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Transgene SA Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oncolys BioPharma
2.5.1 Business Overview
2.5.2 Oncolytic Virus Therapy Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Targovax
2.6.1 Business Overview
2.6.2 Oncolytic Virus Therapy Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Targovax Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PsiOxus Therapeutics
2.7.1 Business Overview
2.7.2 Oncolytic Virus Therapy Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SillaJen Biotherapeutics
2.8.1 Business Overview
2.8.2 Oncolytic Virus Therapy Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sorrento Therapeutics
2.9.1 Business Overview
2.9.2 Oncolytic Virus Therapy Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lokon Pharma
2.10.1 Business Overview
2.10.2 Oncolytic Virus Therapy Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Lokon Pharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genelux Corporation
2.11.1 Business Overview
2.11.2 Oncolytic Virus Therapy Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Genelux Corporation Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Vyriad
2.12.1 Business Overview
2.12.2 Oncolytic Virus Therapy Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Vyriad Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 TILT Biotherapeutics
2.13.1 Business Overview
2.13.2 Oncolytic Virus Therapy Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Cold Genesys
2.14.1 Business Overview
2.14.2 Oncolytic Virus Therapy Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Cold Genesys Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncolytic Virus Therapy Market Competition, by Manufacturer
3.1 Global Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Oncolytic Virus Therapy Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Oncolytic Virus Therapy Manufacturer Market Share in 2017
3.4.2 Top 5 Oncolytic Virus Therapy Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Oncolytic Virus Therapy Market Analysis by Regions
4.1 Global Oncolytic Virus Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Oncolytic Virus Therapy Sales by Regions (2013-2018)
4.1.2 Global Oncolytic Virus Therapy Revenue by Regions (2013-2018)
4.2 North America Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2013-2018)
5 North America Oncolytic Virus Therapy by Countries, Type, Application and Manufacturers
5.1 North America Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Oncolytic Virus Therapy Sales by Countries (2013-2018)
5.1.2 North America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
5.1.3 United States Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
5.1.4 Canada Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
5.1.5 Mexico Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
5.2 North America Oncolytic Virus Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Oncolytic Virus Therapy Sales by Manufacturers (2016-2017)
5.2.2 North America Oncolytic Virus Therapy Revenue by Manufacturers (2016-2017)
5.3 North America Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Oncolytic Virus Therapy Sales and Sales Share by Type (2013-2018)
5.3.2 North America Oncolytic Virus Therapy Revenue and Revenue Share by Type (2013-2018)
5.4 North America Oncolytic Virus Therapy Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Oncolytic Virus Therapy Sales and Sales Share by Application (2013-2018)
5.4.2 North America Oncolytic Virus Therapy Revenue and Revenue Share by Application (2013-2018)
6 Europe Oncolytic Virus Therapy by Countries, Type, Application and Manufacturers
6.1 Europe Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Oncolytic Virus Therapy Sales by Countries (2013-2018)
6.1.2 Europe Oncolytic Virus Therapy Revenue by Countries (2013-2018)
6.1.3 Germany Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.1.4 UK Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.1.5 France Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.1.6 Russia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.1.7 Italy Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.2 Europe Oncolytic Virus Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Oncolytic Virus Therapy Sales by Manufacturers (2016-2017)
6.2.2 Europe Oncolytic Virus Therapy Revenue by Manufacturers (2016-2017)
6.3 Europe Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Oncolytic Virus Therapy Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Oncolytic Virus Therapy Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Oncolytic Virus Therapy Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Oncolytic Virus Therapy Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Oncolytic Virus Therapy Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Oncolytic Virus Therapy by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oncolytic Virus Therapy Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2013-2018)
7.1.3 China Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.1.4 Japan Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.1.5 Korea Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.1.6 India Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Oncolytic Virus Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Oncolytic Virus Therapy Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Oncolytic Virus Therapy Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Oncolytic Virus Therapy Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Oncolytic Virus Therapy Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Oncolytic Virus Therapy Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Oncolytic Virus Therapy Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Oncolytic Virus Therapy Revenue and Revenue Share by Application (2013-2018)
8 South America Oncolytic Virus Therapy by Countries, Type, Application and Manufacturers
8.1 South America Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Oncolytic Virus Therapy Sales by Countries (2013-2018)
8.1.2 South America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
8.1.3 Brazil Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
8.1.4 Argentina Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
8.1.5 Colombia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
8.2 South America Oncolytic Virus Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Oncolytic Virus Therapy Sales by Manufacturers (2016-2017)
8.2.2 South America Oncolytic Virus Therapy Revenue by Manufacturers (2016-2017)
8.3 South America Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Oncolytic Virus Therapy Sales and Sales Share by Type (2013-2018)
8.3.2 South America Oncolytic Virus Therapy Revenue and Revenue Share by Type (2013-2018)
8.4 South America Oncolytic Virus Therapy Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Oncolytic Virus Therapy Sales and Sales Share by Application (2013-2018)
8.4.2 South America Oncolytic Virus Therapy Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Oncolytic Virus Therapy by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oncolytic Virus Therapy Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Oncolytic Virus Therapy Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.1.4 UAE Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.1.5 Egypt Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.1.7 South Africa Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Oncolytic Virus Therapy Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Oncolytic Virus Therapy Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Oncolytic Virus Therapy Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Oncolytic Virus Therapy Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Oncolytic Virus Therapy Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Oncolytic Virus Therapy Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Oncolytic Virus Therapy Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Oncolytic Virus Therapy Revenue and Revenue Share by Application (2013-2018)
10 Global Oncolytic Virus Therapy Market Segment by Type
10.1 Global Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2013-2018)
11 Global Oncolytic Virus Therapy Market Segment by Application
11.1 Global Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
11.2 Melanoma Sales Growth (2013-2018)
11.3 Prostate Cancer Sales Growth (2013-2018)
11.4 Breast Cancer Sales Growth (2013-2018)
11.5 Ovarian Cancer Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Oncolytic Virus Therapy Market Forecast (2018-2023)
12.1 Global Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Oncolytic Virus Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.2 Europe Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.4 South America Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oncolytic Virus Therapy Market Forecast (2018-2023)
12.3 Oncolytic Virus Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Oncolytic Virus Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Oncolytic Virus Therapy Market Share Forecast by Type (2018-2023)
12.4 Oncolytic Virus Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Oncolytic Virus Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Oncolytic Virus Therapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Oncolytic Virus Therapy Picture
Table Product Specifications of Oncolytic Virus Therapy
Figure Global Oncolytic Virus Therapy CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Oncolytic Virus Therapy CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Oncolytic Virus Therapy by Types in 2017
Figure Oncolytic Virus Therapy Sales Market Share by Applications in 2017
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Breast Cancer Picture
Figure Ovarian Cancer Picture
Figure Others Picture
Figure United States Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure France Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure UK Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure China Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure India Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Oncolytic Virus Therapy Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncolytic Virus Therapy Type and Applications
Table Amgen Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors
Table Oncolytics Biotech Oncolytic Virus Therapy Type and Applications
Table Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Viralytics Basic Information, Manufacturing Base and Competitors
Table Viralytics Oncolytic Virus Therapy Type and Applications
Table Viralytics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Transgene SA Basic Information, Manufacturing Base and Competitors
Table Transgene SA Oncolytic Virus Therapy Type and Applications
Table Transgene SA Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolys BioPharma Basic Information, Manufacturing Base and Competitors
Table Oncolys BioPharma Oncolytic Virus Therapy Type and Applications
Table Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Targovax Basic Information, Manufacturing Base and Competitors
Table Targovax Oncolytic Virus Therapy Type and Applications
Table Targovax Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PsiOxus Therapeutics Basic Information, Manufacturing Base and Competitors
Table PsiOxus Therapeutics Oncolytic Virus Therapy Type and Applications
Table PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SillaJen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Type and Applications
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Oncolytic Virus Therapy Type and Applications
Table Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lokon Pharma Basic Information, Manufacturing Base and Competitors
Table Lokon Pharma Oncolytic Virus Therapy Type and Applications
Table Lokon Pharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genelux Corporation Basic Information, Manufacturing Base and Competitors
Table Genelux Corporation Oncolytic Virus Therapy Type and Applications
Table Genelux Corporation Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vyriad Basic Information, Manufacturing Base and Competitors
Table Vyriad Oncolytic Virus Therapy Type and Applications
Table Vyriad Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table TILT Biotherapeutics Oncolytic Virus Therapy Type and Applications
Table TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cold Genesys Basic Information, Manufacturing Base and Competitors
Table Cold Genesys Oncolytic Virus Therapy Type and Applications
Table Cold Genesys Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure Global Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure Global Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table Global Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure Global Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table Global Oncolytic Virus Therapy Price by Manufacturer (2016-2017)
Figure Top 3 Oncolytic Virus Therapy Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Oncolytic Virus Therapy Manufacturer (Revenue) Market Share in 2017
Figure Global Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Global Oncolytic Virus Therapy Sales by Regions (2013-2018)
Table Global Oncolytic Virus Therapy Sales Market Share by Regions (2013-2018)
Table Global Oncolytic Virus Therapy Revenue by Regions (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Regions in 2013
Figure Global Oncolytic Virus Therapy Revenue Market Share by Regions in 2017
Figure North America Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure North America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure South America Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure South America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure North America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table North America Oncolytic Virus Therapy Sales by Countries (2013-2018)
Table North America Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Therapy Sales Market Share by Countries in 2013
Figure North America Oncolytic Virus Therapy Sales Market Share by Countries in 2017
Table North America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Table North America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Therapy Revenue Market Share by Countries in 2013
Figure North America Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure United States Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Canada Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Mexico Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table North America Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure North America Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure North America Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table North America Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure North America Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure North America Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table North America Oncolytic Virus Therapy Sales by Type (2013-2018)
Table North America Oncolytic Virus Therapy Sales Share by Type (2013-2018)
Table North America Oncolytic Virus Therapy Revenue by Type (2013-2018)
Table North America Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Table North America Oncolytic Virus Therapy Sales by Application (2013-2018)
Table North America Oncolytic Virus Therapy Sales Share by Application (2013-2018)
Table North America Oncolytic Virus Therapy Revenue by Application (2013-2018)
Table North America Oncolytic Virus Therapy Revenue Share by Application (2013-2018)
Figure Europe Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Europe Oncolytic Virus Therapy Sales by Countries (2013-2018)
Table Europe Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
Table Europe Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Countries in 2016
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure Germany Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure UK Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure France Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Russia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Italy Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table Europe Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure Europe Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure Europe Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table Europe Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table Europe Oncolytic Virus Therapy Sales by Type (2013-2018)
Table Europe Oncolytic Virus Therapy Sales Share by Type (2013-2018)
Table Europe Oncolytic Virus Therapy Revenue by Type (2013-2018)
Table Europe Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Table Europe Oncolytic Virus Therapy Sales by Application (2013-2018)
Table Europe Oncolytic Virus Therapy Sales Share by Application (2013-2018)
Table Europe Oncolytic Virus Therapy Revenue by Application (2013-2018)
Table Europe Oncolytic Virus Therapy Revenue Share by Application (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Sales by Countries (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Countries 2017
Table Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries 2017
Figure China Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Japan Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Korea Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure India Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Southeast Asia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Oncolytic Virus Therapy Sales by Type (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Sales Share by Type (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Sales by Application (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Sales Share by Application (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Revenue Share by Application (2013-2018)
Figure South America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table South America Oncolytic Virus Therapy Sales by Countries (2013-2018)
Table South America Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Therapy Sales Market Share by Countries in 2017
Table South America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Table South America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure Brazil Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Argentina Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Colombia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table South America Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure South America Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure South America Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Table South America Oncolytic Virus Therapy Revenue by Manufacturer (2016-2017)
Figure South America Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2016
Figure South America Oncolytic Virus Therapy Revenue Market Share by Manufacturer in 2017
Table South America Oncolytic Virus Therapy Sales by Type (2013-2018)
Table South America Oncolytic Virus Therapy Sales Share by Type (2013-2018)
Table South America Oncolytic Virus Therapy Revenue by Type (2013-2018)
Table South America Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Table South America Oncolytic Virus Therapy Sales by Application (2013-2018)
Table South America Oncolytic Virus Therapy Sales Share by Application (2013-2018)
Table South America Oncolytic Virus Therapy Revenue by Application (2013-2018)
Table South America Oncolytic Virus Therapy Revenue Share by Application (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oncolytic Virus Therapy Sales by Countries (2013-2018)
Table Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Countries in 2017
Table Middle East and Africa Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Table Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries in 2013
Figure Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure UAE Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Egypt Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure Nigeria Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Figure South Africa Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
Table Middle East and Africa Oncolytic Virus Therapy Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Manufacturer in 2017
Ta
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liquid Chromatography Detectors Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 109
    Liquid Chromatography Detectors is a device used in liquid chromatography (LC) to detect components of the mixture being eluted off the chromatography column. A broad range of detectors is available to meet different sample requirements. Specific detectors respond to a particular compound only and the response is independent of mobile phase composition. On the other hand the response of bulk property detectors is dependent on collective changes in composition of sample and mobile phase. ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) IV Bags Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 103
    This report studies the IV Bag market including flex plastics bag, semi-rigid IV Bags, glass bottles. Scope of the Report: This report focuses on the IV Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - Baxter - SSY Group - ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Fractional Flow Reserve Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). Scope of the Report: This report focuses on the Fractional Flow Reserve in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle Eas......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Scope of the Report: This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in Global market, especially in North America,......
  • North America and Europe APAC Hydrocolloid Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    A hydrocolloid dressing is an opaque or transparent dressing for wounds. A hydrocolloid dressing is biodegradeable, non-breathable, and adheres to the skin, so no separate taping is needed. Scope of the Report: This report focuses on the APAC Hydrocolloid in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and appl......
  • North America and Europe APAC Silver Dressing Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 103
    Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a wound dressing impregnated with ionic silver. The ionic silver is responsible for the anti-microbial activity against infection caused by bacteria. Scope of the Report: This report focuses on the APAC Silver Dressing in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy an......
  • North America and Europe Breast Lesion Localization Methods Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 109
    This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products. Scope of the Report: This report focuses on the Breast Lesion Localization Methods in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application......
  • North America and Europe Casting and Splinting Products Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    An orthopedic cast, or simply cast, is a shell, frequently made from plaster or fiberglass, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed. It is similar in function to a splint. Scope of the Report: This report focuses on the Casting and Splinting Products in North America and Europe market, especially in United States, United Kingd......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Orally Disintegrating Tablet Market 2018 Forecast to 2023
    Published: 27-Apr-2018        Price: US 4880 Onwards        Pages: 102
    An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs